Intervacc AB (publ) (STO:IVACC)
1.094
+0.010 (0.92%)
Sep 2, 2026, 5:29 PM CET
Intervacc AB Revenue
Intervacc AB had revenue of 6.75M SEK in the quarter ending June 30, 2026, a decrease of -8.61%. This brings the company's revenue in the last twelve months to 20.63M, up 4.80% year-over-year. In the year 2025, Intervacc AB had annual revenue of 22.28M with 74.13% growth.
Revenue (ttm)
20.63M
Revenue Growth
+4.80%
P/S Ratio
20.58
Revenue / Employee
1.13M
Employees
16
Market Cap
372.85M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 22.28M | 9.49M | 74.13% |
| Dec 31, 2024 | 12.80M | 3.03M | 30.97% |
| Dec 31, 2023 | 9.77M | -3.31M | -25.30% |
| Dec 31, 2022 | 13.08M | 1.64M | 14.35% |
| Dec 31, 2021 | 11.44M | 1.65M | 16.87% |
| Dec 31, 2020 | 9.79M | -7.79M | -44.32% |
| Dec 31, 2019 | 17.58M | -21.16M | -54.62% |
| Dec 31, 2018 | 38.73M | -12.11M | -23.83% |
| Dec 31, 2017 | 50.85M | -7.16M | -12.34% |
| Dec 31, 2016 | 58.00M | -6.75M | -10.43% |
| Dec 31, 2015 | 64.76M | -15.45M | -19.26% |
| Dec 31, 2014 | 80.21M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cantargia AB | 317.31M |
| Sprint Bioscience AB | 138.95M |
| Oncopeptides AB | 95.15M |
| Xbrane Biopharma AB | 83.30M |
| IRLAB Therapeutics AB | 79.33M |
| Corline Biomedical AB | 11.85M |
| Elicera Therapeutics AB | 7.79M |
| Xspray Pharma AB | 2.47M |
Intervacc AB News
- 13 days ago - Intervacc AB Quarterly report: Q2 2026 - Filings
- 14 days ago - Earnings To Watch: Intervacc AB (OSTO:IVACC) Q2 2026 -- GF Value Sees 24% Downside - GuruFocus
- 3 months ago - Intervacc AB Quarterly report: Q1 2026 - Filings
- 3 months ago - Intervacc AB (OSTO:IVACC) Q1 2026: Everything You Need to Know Ahead of Earnings - GuruFocus
- 5 months ago - Intervacc AB Slides: FY 2026 - Filings
- 6 months ago - Intervacc AB Quarterly report: Q4 2025 - Filings
- 6 months ago - Intervacc AB Annual report: Q4 2025 - Filings
- 6 months ago - Earnings To Watch: Intervacc AB (OSTO:IVACC) Reports Q4 2025 Result - GuruFocus